Zosano Pharma Corp (Over The Counter Market:ZSANQ)

0.0002
Delayed Data
As of Dec 08
 0.00 / 0.00%
Today’s Change
0.00
Today|||52-Week Range
24.80
-100.00%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues313.0K0.000.000.00
 
 
Depreciation And Amortization2.5M2.5M2.6M764.0K
 
 
 
 
 
 
Operating ExpensesGross Income-2.1M-2.5M-2.6M-764.0K
 
 
 
 
 
General Expenses24.2M25.2M25.8M34.1M
 
 
 
 
 
Research And Development20.4M20.5M20.2M24.7M
 
 
 
 
 
Total Operating Expenses26.7M27.7M28.4M34.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-26.4M-27.7M-28.4M-34.9M
 
 
 
 
 
Extraordinary Credit48.0K0.000.000.00
 
 
Extraordinary Charge-543.0K-900.0K0.00-511.0K
 
 
 
 
Interest Expense On Debt1.8M1.2M742.0K679.0K
 
 
 
 
 
Other Expenses0.00-7.0K7.0K16.0K
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-28.4M-29.8M-29.1M-35.4M
 
 
 
 
 
Net Income-28.4M-29.8M-29.1M-35.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS570.7K688.7K1.7M9.5M
 
 
 
 
 
Shares To Calculate EPS Diluted570.7K688.7K1.7M9.5M
 
 
 
 
 
 
Earnings Per ShareEPS-$49.80-$43.40-$16.82-$3.74
 
 
 
 
 
EPS Diluted-$49.80-$43.40-$16.82-$3.74